First entecavir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Nirmatrelvir 150mg tablets + ritonavir 100mg tablets invited for COVID-19.
See full report:
A nitrosamine impurity, 1-methyl-4-nitrosopiperazine (MeNP), was identified in rifampicin products.
A 1st Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published by
Casirivimab and imdevimab combination invited for COVID-19.
Tocilizumab and sarilumab invited for COVID-19.